Category: Pharmaceutical company Industry: Drug Manufacturers - Major Quick infos Headquarters: Kenilworth, New Jersey, United States Trade prices Volume: 6.2M Market Cap: 233.71B Prev closed: 79.21 Open: 79.26 High: 80.62 Low: 79.26 52 week low: 65.25 52 week high: 92.64 Dividends: Next ER: April 27, 2023 Before Market Opens
About the Company
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world.
Date EPS / Forecast Revenue / Forecast August 1, 2023 April 27, 2023 1.4 / 1.35 14.49B / 13.78B Beat! February 2, 2023 1.62 / 1.53 13.8B / 13.65B Beat! October 27, 2022 1.85 / 1.75 15B / 14.07B Beat! July 28, 2022 1.87 / 1.7 14.59B / 13.86B Beat! view more
NYSE - New York Stock Exchange
More profiles and info about the company ISIN: US58933Y1055 CUSIP: 58933Y105 Founded: 1891, New York, United States Employees: 68,000 News FDA Approves Mercks KEYTRUDA® (pembrolizumab) in Combination With Padcev® (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer finance.yahoo.com Apr 17, 2023 5:00 pm 12 Best Diversified Dividend Stocks to Buy Now finance.yahoo.com Apr 17, 2023 3:10 pm UPDATE 1-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return finance.yahoo.com Apr 17, 2023 2:14 pm Merck Ranked No. 1 in the Pharmaceutical Industry Among Barrons 100 Most Sustainable U.S. Companies 2023 finance.yahoo.com Apr 17, 2023 1:10 pm Merck's Keytruda Combo Therapy Less Effective Than Chemo In Lung Cancer Patients, Data Shows finance.yahoo.com Apr 17, 2023 12:22 pm Health Rounds: Waiting to remove lymph nodes may improve cancer immunotherapy finance.yahoo.com Apr 17, 2023 11:55 am Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover finance.yahoo.com Apr 17, 2023 11:15 am FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer finance.yahoo.com Apr 17, 2023 11:08 am Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return finance.yahoo.com Apr 17, 2023 11:04 am Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection versus KEYTRUDA finance.yahoo.com Apr 17, 2023 11:00 am Top Research Reports for Merck, Intel & MercadoLibre finance.yahoo.com Apr 17, 2023 10:52 am US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities finance.yahoo.com Apr 17, 2023 9:47 am Stocks trade higher at the open, tech sees gains finance.yahoo.com Apr 17, 2023 9:42 am Mercks combination therapy in lung cancer fails a Phase 2 clinical trial finance.yahoo.com Apr 17, 2023 8:08 am The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton finance.yahoo.com Apr 17, 2023 7:21 am Technical Assessment: Bearish in the Intermediate-Term finance.yahoo.com Apr 17, 2023 6:53 am Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27 finance.yahoo.com Apr 17, 2023 6:45 am Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023? finance.yahoo.com Apr 17, 2023 6:26 am Stocks Nudge Higher, Earnings On Deck, Merck Buys Prometheus, Netflix Axes 'Love Is Blind', Charles Schwab Reports - Five Things To Know finance.yahoo.com Apr 17, 2023 6:11 am Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc. finance.yahoo.com Apr 17, 2023 6:00 am MRK Dividends
Ex-Dividend Amount Announced Date Record Date Payment Date Mar 14, 2023 0.73 Apr 10, 2023 Dec 14, 2022 0.73 Jan 9, 2023 Sep 14, 2022 0.69 Oct 7, 2022 Jun 14, 2022 0.69 Jul 8, 2022 Mar 14, 2022 0.69 Apr 7, 2022 view more Key Persons Talk about Merck below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: merck.com
Consensus BUY 86 HOLD 14 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.